Companion Diagnostics for Oncology Market was valued at USD 2.5 Billion in 2032 and is expected to register a CAGR of 21.1% during the forecast period of 2023 to 2032. In the realm of modern medicine, the field of oncology stands at the forefront of innovation, constantly seeking novel approaches to improve patient outcomes. Among the latest advancements driving this progress is the...